The evolving field of medicine presents the surgeon with a vast array of powerful cellular and molecular tools for achieving previously impossible results.
These powerful tools require efficient and effective delivery platforms lest valuable materials are lost in inactive matrices or configurations, or worse yet, become waste product from cumbersome in-surgery preparation procedures.
Bioactive Surgical, Inc. is developing a range of delivery systems. The company’s patent pending technologies offer both the practicing surgeon and the research scientist new opportunities for delivering targeted doses in a manner which minimizes loss or inefficient use.
Our proprietary delivery platforms provide options in both the engineered materials field as well as in the exciting field of systems based totally on compounds which occur naturally in the body.
We are the Stem Cell Suture ™ people.